Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 168

Results For "FY"

2442 News Found

USFDA completes two cGMP inspections at Biocon Biologics' insulins facility in Malaysia
Drug Approval | July 24, 2023

USFDA completes two cGMP inspections at Biocon Biologics' insulins facility in Malaysia

The agency issued a Form 483 with 6 observations for Drug Substance, Drug Product units and Quality Control laboratories


PrecisionLife identifies first detailed genetic risk factors for long COVID
News | July 19, 2023

PrecisionLife identifies first detailed genetic risk factors for long COVID

Long COVID is a debilitating chronic condition that has affected over 100 million people globally


PredOmix, Core Diagnostics partner to launch OncoVeryx-F
Clinical Trials | July 18, 2023

PredOmix, Core Diagnostics partner to launch OncoVeryx-F

OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection


PrecisionLife Licenses University of Oxford data to discover personalised treatments for endometriosis patients
News | July 07, 2023

PrecisionLife Licenses University of Oxford data to discover personalised treatments for endometriosis patients

PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis and identify novel drug targets to support the development of new personalised treatments


Aarti Drugs bags Pharmexcil Outstanding Exports Awards 2021-22
News | July 07, 2023

Aarti Drugs bags Pharmexcil Outstanding Exports Awards 2021-22

The company has received Export Performance Award - API & Intermediaries Gold Star for the year 2021-22


Syngene to acquire multi-modal facility from Stelis Biopharma
News | July 05, 2023

Syngene to acquire multi-modal facility from Stelis Biopharma

Adding 20,000 liters of installed biologics drug substance manufacturing capacity


Zydus receives final approval from the USFDA for Oxcarbazepine Tablets
Drug Approval | July 05, 2023

Zydus receives final approval from the USFDA for Oxcarbazepine Tablets

The product will be manufactured at the group's formulation manufacturing facility in Baddi, Himachal Pradesh (India)


CARE reaffirms A+ rating to IOL Chemicals and Pharmaceuticals
News | July 05, 2023

CARE reaffirms A+ rating to IOL Chemicals and Pharmaceuticals

The 'A+' rating reflects IOL's robust business model, diversified product portfolio


Healthium Medtech appoints Dr. Vivek S. Iyer as GM for Professional Education & Market Growth Strategy
People | July 05, 2023

Healthium Medtech appoints Dr. Vivek S. Iyer as GM for Professional Education & Market Growth Strategy

Dr. Vivek joins Healthium after a stint at Ethicon, Johnson & Johnson


Annovis’ Buntanetap in PD faces complex road ahead despite phase III progress, says GlobalData
News | July 03, 2023

Annovis’ Buntanetap in PD faces complex road ahead despite phase III progress, says GlobalData

The positive safety review from the DSMB enables the trial to move forward as planned, with an estimated completion date in December 2023